{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:46:56Z","timestamp":1786985216275,"version":"build-2736575974"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"am","delay-in-days":339,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007737","name":"St. Jude Children's Research Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000150","name":"Office of Emerging Frontiers and Multidisciplinary Activities","doi-asserted-by":"publisher","award":["CEE20127"],"award-info":[{"award-number":["CEE20127"]}],"id":[{"id":"10.13039\/100000150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000150","name":"Office of Emerging Frontiers and Multidisciplinary Activities","doi-asserted-by":"publisher","award":["CEE 2017079"],"award-info":[{"award-number":["CEE 2017079"]}],"id":[{"id":"10.13039\/100000150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["NS108376"],"award-info":[{"award-number":["NS108376"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["CA225945"],"award-info":[{"award-number":["CA225945"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006279","name":"St. Jude Medical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006279","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100023029","name":"Fulbright Program","doi-asserted-by":"publisher","award":["R35GM142772"],"award-info":[{"award-number":["R35GM142772"]}],"id":[{"id":"10.13039\/100023029","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100023029","name":"Fulbright Program","doi-asserted-by":"publisher","award":["2610\/F-N APE\/2020"],"award-info":[{"award-number":["2610\/F-N APE\/2020"]}],"id":[{"id":"10.13039\/100023029","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002108","name":"Friedreich's Ataxia Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006222","name":"United States - India Educational Foundation","doi-asserted-by":"publisher","award":["pET28a-BRD2-BD2"],"award-info":[{"award-number":["pET28a-BRD2-BD2"]}],"id":[{"id":"10.13039\/100006222","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006224","name":"Argonne National Laboratory","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006224","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012524","name":"ALSAC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012524","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003187","name":"NSF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003187","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bioorg.2025.108813","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T21:11:27Z","timestamp":1754428287000},"page":"108813","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Positional isomers of Indolyl-benzodiazepines display dissimilar binding and recruitment of BET transcriptional regulators to targeted genomic loci"],"prefix":"10.1016","volume":"164","author":[{"given":"Nilanjana","family":"Chowdhury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Nithianantham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudip","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafi","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Churion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Philips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sourav","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bedabrata","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anang","family":"Shelat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aseem Z.","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parasuraman","family":"Jaisankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.108813_bb0005","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1038\/s41416-021-01321-0","article-title":"Achieving clinical success with BET inhibitors as anti-cancer agents","volume":"124","author":"Shorstova","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bioorg.2025.108813_bb0010","first-page":"62","article-title":"Bromodomain and extra-terminal family protein inhibitors: a potentially new therapy for heart disease","volume":"2","author":"Mu","year":"2021","journal-title":"J Clin Cardiol."},{"key":"10.1016\/j.bioorg.2025.108813_bb0015","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.cell.2012.02.013","article-title":"Histone recognition and large-scale structural analysis of the human bromodomain family","volume":"149","author":"Filippakopoulos","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2025.108813_bb0020","first-page":"288","article-title":"Druggability analysis and structural classification of bromodomain acetyl-lysine binding sites","volume":"5","author":"Vidler","year":"2014","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.bioorg.2025.108813_bb0025","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nature08397","article-title":"Cooperative binding of two acetylation marks on a histone tail by a single bromodomain","volume":"461","author":"Morinie\u2019re","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2025.108813_bb0030","doi-asserted-by":"crossref","first-page":"7346","DOI":"10.1021\/jm300346w","article-title":"Druggability analysis and structural classification of Bromodomain acetyl-lysine binding sites","volume":"55","author":"Vidler","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108813_bb0035","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrd4286","article-title":"Targeting bromodomains: epigenetic readers of lysine acetylation","volume":"13","author":"Filippakopoulos","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2025.108813_bb0040","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/nature09589","article-title":"Suppression of inflammation by a synthetic histone mimic","volume":"468","author":"Nicodeme","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2025.108813_bb0045","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.1021\/acs.jmedchem.1c01703","article-title":"NMR molecular replacement provides new insights into binding modes to bromodomains of BRD4 and TRIM24","volume":"65","author":"Torres","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108813_bb0050","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature09504","article-title":"Selective inhibition of BET bromodomains","volume":"468","author":"Filippakopoulos","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2025.108813_bb0055","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1158\/1078-0432.CCR-13-2281","article-title":"BET bromodomain inhibition of MYC-amplified medulloblastoma","volume":"20","author":"Bandopadhayay","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2025.108813_bb0060","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/cancers13143470","article-title":"The BET inhibitor JQ1 augments the antitumor efficacy of gemcitabine in preclinical models of pancreatic cancer","volume":"13","author":"Miller","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bioorg.2025.108813_bb0065","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1158\/1538-7445.AM2017-CT104","article-title":"A first-in-human phase I dose escalation study of BET inhibitor GSK2820151 in patients with advanced or recurrent solid tumors cancers","volume":"77","author":"Shirish Gadgeel","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2025.108813_bb0070","doi-asserted-by":"crossref","first-page":"17698","DOI":"10.18632\/oncotarget.4131","article-title":"BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cells","volume":"6","author":"Coude","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioorg.2025.108813_bb0075","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41586-020-1930-8","article-title":"Selective inhibition of the BD2bromodomain of BET proteins in prostate cancer","volume":"578","author":"Faivre","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2025.108813_bb0080","doi-asserted-by":"crossref","first-page":"9070","DOI":"10.1021\/acs.jmedchem.0c00605","article-title":"Design and synthesis of a highly selective and in vivo-capable inhibitor of the second bromodomain of the Bromodomain and extra terminal domain family of proteins","volume":"63","author":"Preston","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108813_bb0085","doi-asserted-by":"crossref","first-page":"9093","DOI":"10.1021\/acs.jmedchem.0c00796","article-title":"The optimisation of a novel, weak bromo and extra terminal domain (BET) bromodomain fragment ligand to a potent and selective second bromodomain (BD2) inhibitor","volume":"63","author":"Seal","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108813_bb0090","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1126\/science.aaz8455","article-title":"Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation","volume":"368","author":"Gilan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2025.108813_bb0095","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1126\/science.1249830","article-title":"A bump-and-hole approach to engineer-controlled selectivity of BET bromodomain chemical probes","volume":"346","author":"Baud","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2025.108813_bb0100","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1021\/acs.jmedchem.5b01135","article-title":"New synthetic routes to triazolo-benzodiazepine analogs: expanding the scope of the bump-and-hole approach for selective bromo and extra-terminal (BET) bromodomain inhibition","volume":"59","author":"Baud","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108813_bb0105","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1021\/acsomega.7b00780","article-title":"Gram-scale laboratory synthesis of TCAC 28, a high-affinity BET bromodomain ligand","volume":"2","author":"Khan","year":"2017","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2025.108813_bb0110","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1126\/science.aan6414","article-title":"Synthetic transcription elongation factors license transcription across repressive chromatin","volume":"358","author":"Erwin","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2025.108813_bb0115","doi-asserted-by":"crossref","first-page":"E7418","DOI":"10.1073\/pnas.1604847113","article-title":"Synthetic genome readers target clustered binding sites across diverse chromatin states proc","volume":"113","author":"Erwin","year":"2016","journal-title":"Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bioorg.2025.108813_bb0120","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0968-0896(01)00262-0","article-title":"Molecular recognition of DNA by small molecules","volume":"9","author":"Dervan","year":"2001","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108813_bb0125","doi-asserted-by":"crossref","first-page":"11497","DOI":"10.1073\/pnas.0604939103","article-title":"DNA sequence-specific polyamides alleviate transcription inhibition associated with long GAA.TTC repeats in Friedreich\u2019s ataxia","volume":"103","author":"Burnett","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bioorg.2025.108813_bb0130","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/hmg\/6.11.1771","article-title":"Frataxin is reduced in Friedreich ataxia patients and misassociated with mitochondrial membranes","volume":"6","author":"Campuzano","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bioorg.2025.108813_bb0135","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.1098991","article-title":"Frataxin acts as an iron chaperone protein to modulate mitochondrial aconitase activity","volume":"305","author":"Bulteau","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2025.108813_bb0140","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/nsmb.1579","article-title":"Bacterial frataxin CyaY is the gatekeeper of iron-sulfur cluster formation catalyzed by IscS","volume":"16","author":"Adinolfi","year":"2009","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bioorg.2025.108813_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2014.00029","article-title":"Mitochondrial iron\u2013sulfur cluster dysfunction in neurodegenerative disease","volume":"5","author":"Isaya","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108813_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fgene.2014.00165","article-title":"Epigenetic-based therapies for Friedreich ataxia","volume":"5","author":"Sandi","year":"2014","journal-title":"Front. Genet."},{"key":"10.1016\/j.bioorg.2025.108813_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104606","article-title":"Friedreich ataxia- pathogenesis and implications for therapies","volume":"132","author":"Delatycki","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bioorg.2025.108813_bb0160","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/mt.2015.41","article-title":"Excision of expanded GAA repeats alleviates the molecular phenotype of Friedreich\u2019s Ataxia","volume":"23","author":"Li","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bioorg.2025.108813_bb0165","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1007\/s13311-019-00764-x","article-title":"Molecular mechanisms, and therapeutics for the GAA\u00b7TTC expansion disease Friedreich Ataxia","volume":"16","author":"Gottesfeld","year":"2019","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.bioorg.2025.108813_bb0170","first-page":"24568","article-title":"Domain-selective BET ligands yield next-generation synthetic genome readers\/regulators with non-identical cellular function","volume":"145","author":"Mohammed","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2025.108813_bb0175","first-page":"1","article-title":"Shi, Y, solution structure of the second bromodomain of Brd2 and its specific interaction with acetylated histone tails","volume":"57","author":"Huang","year":"2007","journal-title":"BMC Struct. Biol."},{"key":"10.1016\/j.bioorg.2025.108813_bb0180","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1016\/j.febslet.2010.08.013","article-title":"Structural implications for K5\/K12-di-acetylated histone H4 recognition by the second bromodomain of BRD2","volume":"584","author":"Umehara","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bioorg.2025.108813_bb0185","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1021\/jm200108t","article-title":"Discovery and characterization of small molecule inhibitors of the BET family bromodomains","volume":"54","author":"Chung","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108813_bb0190","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/ijc.33861","article-title":"Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of nuclear protein of the testis carcinoma and other cancers: results of a phase I\/II open-label, dose escalation study","volume":"150","author":"Cousin","year":"2022","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bioorg.2025.108813_bb0195","doi-asserted-by":"crossref","first-page":"15818","DOI":"10.1021\/jacs.9b06275","article-title":"Water networks can determine the affinity of ligand binding to proteins","volume":"141","author":"Darby","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2025.108813_bb0200","doi-asserted-by":"crossref","first-page":"6141","DOI":"10.1021\/ja960720z","article-title":"Solid phase synthesis of polyamides containing imidazole and pyrrole amino acids","volume":"118","author":"Baird","year":"1996","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2025.108813_bb0205","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1158\/0008-5472.CAN-19-3934","article-title":"Bromodomain-selective BET inhibitors are potent antitumor agents against MYC-driven pediatric Cancer","volume":"80","author":"Slavish","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2025.108813_bb0210","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","article-title":"Processing of X-ray diffraction data collected in oscillation mode","volume":"276","author":"Otwinowski","year":"1997","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bioorg.2025.108813_bb0215","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.bioorg.2025.108813_bb0220","first-page":"486","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr."},{"key":"10.1016\/j.bioorg.2025.108813_bb0225","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.bioorg.2025.108813_bb0230","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J. Comput. Aid. Mol. Des."},{"key":"10.1016\/j.bioorg.2025.108813_bb0235","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/s41467-024-44698-1","article-title":"Selective CK1\u03b1 degraders exert antiproliferative activity against a broad range of human cancer cell lines","volume":"15","author":"Nishiguchi","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2025.108813_bb0240","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825006935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825006935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T02:28:05Z","timestamp":1762223285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825006935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":48,"alternative-id":["S0045206825006935"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108813","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Positional isomers of Indolyl-benzodiazepines display dissimilar binding and recruitment of BET transcriptional regulators to targeted genomic loci","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108813","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108813"}}